Abbott's New Leadless Pacemaker System Meets Primary Endpoints in Pivotal Trial
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St futures jump as Democrats sweep midterms
- CVS Health plans to split into two public companies by 2028
- UBS starts bullish coverage on Ferrari Group on luxury logistics growth
- Citi cuts Adobe rating on ’rising risk of a hard reset’
- Apple shares slip amid guidance for tightening margins, slowing services growth
| Abbott Laboratories (NYSE: ABT) | Delayed: 109.40 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $109.40 | 52 Week High | $46.38 | |||
| Open | $109.40 | 52 Week Low | $36.00 | |||
| Day High | $109.40 | P/E | 72.93 | |||
| Day Low | $109.40 | EPS | $1.50 | |||
| Volume | 11,692 | |||||
